Surgical antimicrobial prophylaxis in Japanese hospitals : Real status and challenges
Copyright © 2024 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights reserved..
BACKGROUND: Information regarding the status of surgical antimicrobial prophylaxis (SAP) in Japanese hospitals is lacking. This study aimed to explore the status of SAP prescriptions for surgeries and adherence to Japanese SAP guidelines.
METHODS: From February to July 2020, a 1-day multicentre point prevalent survey was conducted at 27 hospitals in Aichi Prefecture, Japan. Patients prescribed SAP were included in this study. The appropriateness of the SAP was evaluated based on the guidelines for selection of antimicrobials and their duration. Surgery was defined as appropriate when all the items were appropriate.
RESULTS: A total of 728 patients (7.1 %; 728/10,199) received antimicrobials for SAP. Among them, 557 patients (76.5 %, 557/728) underwent the surgeries described in the guidelines. The overall appropriateness of all surgeries was 33.9 % (189/557). The appropriate selection of antimicrobial before/during and after surgery and their durations were 67.5 % (376/557), 67.5 % (376/557), and 43.3 % (241/557), respectively. The overall appropriateness ranged from 0 % (0/37, oral and maxillofacial surgery) to 58.7 % (88/150, orthopaedic surgery) and 27.7 % (36/130, community hospitals with 400-599 beds) to 47.2 % (17/36, specific hospitals). Cefazolin was the most prevalent antimicrobial prescribed before/during (55.5 %, 299/539), and after (45.1 %, 249/552) surgery. In total, 101 oral antimicrobials were prescribed postoperatively.
CONCLUSIONS: SAP adherence by specific surgical fields and hospitals was shown in this study. Intensive intervention and repeated surveillance are necessary to improve SAP prescriptions in Japanese hospitals.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
|---|---|
| Enthalten in: |
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy - (2024) vom: 23. Jan. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Morioka, Hiroshi [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 28.01.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1016/j.jiac.2024.01.013 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367626756 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367626756 | ||
| 003 | DE-627 | ||
| 005 | 20240129232150.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240126s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jiac.2024.01.013 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1274.xml |
| 035 | |a (DE-627)NLM367626756 | ||
| 035 | |a (NLM)38272262 | ||
| 035 | |a (PII)S1341-321X(24)00023-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Morioka, Hiroshi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Surgical antimicrobial prophylaxis in Japanese hospitals |b Real status and challenges |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 28.01.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Copyright © 2024 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights reserved. | ||
| 520 | |a BACKGROUND: Information regarding the status of surgical antimicrobial prophylaxis (SAP) in Japanese hospitals is lacking. This study aimed to explore the status of SAP prescriptions for surgeries and adherence to Japanese SAP guidelines | ||
| 520 | |a METHODS: From February to July 2020, a 1-day multicentre point prevalent survey was conducted at 27 hospitals in Aichi Prefecture, Japan. Patients prescribed SAP were included in this study. The appropriateness of the SAP was evaluated based on the guidelines for selection of antimicrobials and their duration. Surgery was defined as appropriate when all the items were appropriate | ||
| 520 | |a RESULTS: A total of 728 patients (7.1 %; 728/10,199) received antimicrobials for SAP. Among them, 557 patients (76.5 %, 557/728) underwent the surgeries described in the guidelines. The overall appropriateness of all surgeries was 33.9 % (189/557). The appropriate selection of antimicrobial before/during and after surgery and their durations were 67.5 % (376/557), 67.5 % (376/557), and 43.3 % (241/557), respectively. The overall appropriateness ranged from 0 % (0/37, oral and maxillofacial surgery) to 58.7 % (88/150, orthopaedic surgery) and 27.7 % (36/130, community hospitals with 400-599 beds) to 47.2 % (17/36, specific hospitals). Cefazolin was the most prevalent antimicrobial prescribed before/during (55.5 %, 299/539), and after (45.1 %, 249/552) surgery. In total, 101 oral antimicrobials were prescribed postoperatively | ||
| 520 | |a CONCLUSIONS: SAP adherence by specific surgical fields and hospitals was shown in this study. Intensive intervention and repeated surveillance are necessary to improve SAP prescriptions in Japanese hospitals | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Koizumi, Yusuke |e verfasserin |4 aut | |
| 700 | 1 | |a Watariguchi, Toshitaka |e verfasserin |4 aut | |
| 700 | 1 | |a Oka, Keisuke |e verfasserin |4 aut | |
| 700 | 1 | |a Tomita, Yuka |e verfasserin |4 aut | |
| 700 | 1 | |a Kojima, Yumi |e verfasserin |4 aut | |
| 700 | 1 | |a Okudaira, Masami |e verfasserin |4 aut | |
| 700 | 1 | |a Ito, Yuji |e verfasserin |4 aut | |
| 700 | 1 | |a Shimizu, Junichi |e verfasserin |4 aut | |
| 700 | 1 | |a Watamoto, Koichi |e verfasserin |4 aut | |
| 700 | 1 | |a Kato, Hiroki |e verfasserin |4 aut | |
| 700 | 1 | |a Nagaoka, Masatoshi |e verfasserin |4 aut | |
| 700 | 1 | |a Yokota, Manabu |e verfasserin |4 aut | |
| 700 | 1 | |a Hasegawa, Chihiro |e verfasserin |4 aut | |
| 700 | 1 | |a Tsuji, Takeshi |e verfasserin |4 aut | |
| 700 | 1 | |a Shimizu, Shinsuke |e verfasserin |4 aut | |
| 700 | 1 | |a Ito, Kenta |e verfasserin |4 aut | |
| 700 | 1 | |a Kawasaki, Shohei |e verfasserin |4 aut | |
| 700 | 1 | |a Akita, Kenji |e verfasserin |4 aut | |
| 700 | 1 | |a Kitagawa, Yuichi |e verfasserin |4 aut | |
| 700 | 1 | |a Mutoh, Yoshikazu |e verfasserin |4 aut | |
| 700 | 1 | |a Ishihara, Masamitsu |e verfasserin |4 aut | |
| 700 | 1 | |a Iwata, Susumu |e verfasserin |4 aut | |
| 700 | 1 | |a Nozaki, Yasuhiro |e verfasserin |4 aut | |
| 700 | 1 | |a Nozawa, Masanori |e verfasserin |4 aut | |
| 700 | 1 | |a Kato, Munehiro |e verfasserin |4 aut | |
| 700 | 1 | |a Katayama, Masao |e verfasserin |4 aut | |
| 700 | 1 | |a Yagi, Tetsuya |e verfasserin |4 aut | |
| 700 | 0 | |a Research Group of Aichi Point Prevalence Survey |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy |d 1996 |g (2024) vom: 23. Jan. |w (DE-627)NLM095488073 |x 1437-7780 |7 nnns |
| 773 | 1 | 8 | |g year:2024 |g day:23 |g month:01 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jiac.2024.01.013 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 23 |c 01 | ||